NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased Marex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

A partnership including: REDF, SRC LCM Partners LONDON , Nov. 17, 2025 /PRNewswire/ -- Under the patronage and presence of His Excellency Mr. Majed bin Abdullah Al-Hogail, Minister of Municipal and Rural Affairs and Housing and Chairman of the Board of the Real Estate Development Fund, the Real Estate Development Fund (REDF) and the Saudi Real Estate Refinance Company (SRC), announced the signing of a tripartite partnership with LCM Partners.

It's been a very strong quarter for big tech earnings, but that meant much for the share prices of the season's earnings beaters.

The central question facing investors heading into 2026 is whether market performance will finally extend beyond the handful of megacap technology companies that have dominated returns for the past three years.

XPeng delivered a standout Q3'25, with sales up over 100% and EV deliveries surging 149% year-over-year. XPEV's affordable Mona EV lineup drove record volumes, while the company pushes into robotaxi and humanoid robot markets, boosting its tech profile. Despite strong sales and improving margins, XPEV remains unprofitable, but forecasts a small Q4 profit and holds a solid cash position.

Anixa Biosciences, Inc. ( ANIX ) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs November 11, 2025 2:00 PM EST Company Participants Amit Kumar - CEO, Chairman & Co-Chair of CBAB Conference Call Participants Robert Sassoon - Water Tower Research LLC Presentation Robert Sassoon Water Tower Research LLC Hello, everybody. I'm Robert Sassoon.

BioNTech SE ( BNTX ) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies November 11, 2025 9:00 AM EST Company Participants Ugur Sahin - Co-Founder, CEO & Chair of the Management Board Özlem Türeci - Co-Founder, Chief Medical Officer & Member of Management Board Ilhan Celik Michael Wenger Ramón Zapata-Gomez - CFO & Member of Management Board Douglas Maffei - Vice President of Strategy & Investor Relations Annemarie Hanekamp - Chief Commercial Officer & Member of Management Board Conference Call Participants Daina Graybosch - Leerink Partners LLC, Research Division Tazeen Ahmad - BofA Securities, Research Division Jay Lee …

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.14 per share a year ago.

BP was responding to a release of refined products on the Olympic Pipeline System east of Everett, Washington, and had partially restored part of the system, the company said on Monday.

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it priced $850 million aggregate principal amount of its 6.500% senior notes due 2031 (the “Notes”) to be sold in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons outside the United States in reliance on Regulation S under.

LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today announced its fourth major Vida portfolio acquisition of 2025, capping an unprecedented year of strategic exits and reinforcing the firm's disciplined, science-first approach to company building and investing. Earlier today, Halda Therapeutics announced its acquisition by Johnson & Johnson (NYSE: JNJ) for $3.05 billion, marking a historic moment for the Vida III portfolio. Hald.

Stephen Gengaro, Stifel, joins 'Fast Money' to talk his bullish take on Tesla.

Archer Aviation said on Monday it will supply its electric powertrain for the Omen autonomous air vehicle, being co-developed by U.S. defense technology firm Anduril Industries and UAE-based EDGE group.

Jim Bianco (@BiancoResearch) says inflation is a bigger problem for the economy instead of jobs. He explains how the "K-shaped economy" many experts have hinted toward is closely tied to rising inflation, using Target (TGT) as a barometer for his metrics.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Quanex Building Products Corporation (NYSE: NX) between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”). Quanex is an international supplier of engineered home components and access solutions to the construction industry. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. T.

DUBAI, United Arab Emirates--(BUSINESS WIRE)---- $ACHR--Archer Aviation Inc. (NYSE: ACHR) today announced an agreement to supply Anduril Industries and EDGE Group with Archer's dual use electric powertrain technology to accelerate the development and scaled production of Anduril's recently unveiled Omen Autonomous Air Vehicle system. The UAE has committed to an initial acquisition of 50 Omen systems, creating an established demand signal for the Omen system and Archer's powertrain technology. The agreeme.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BLUE OWL CAPITAL INC. (OWL), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 16, 2025, the Financial Times published an article d.

Flexible Solutions International, Inc. ( FSI ) Q3 2025 Earnings Call November 17, 2025 11:00 AM EST Company Participants Daniel O'Brien - President, CEO, Principal Financial & Accounting Officer and Director Conference Call Participants Timothy Clarkson - Van Clemens & Co. Incorporated David Marsh - Singular Research, LLC Gregg Hillman William Gregozeski - Greenridge Global LLC Manny Stoupakis - Geoinvesting, LLC Raymond Howe Presentation Operator Good day, everyone, and welcome to today's Flexible Solutions International's Third Quarter 2025 Financials Conference Call. [Operator Instructions] Please note, this call is being recorded, and I will be standing by if you should need …

JinkoSolar Holding Co., Ltd. ( JKS ) Q3 2025 Earnings Call November 17, 2025 7:30 AM EST Company Participants Stella Wang - Investor Relations Officer Xiande Li - Co-Founder, CEO & Chairman of the Board Gener Miao Mengmeng Li - Chief Financial Officer Haiyun Cao - CFO & Deputy GM Conference Call Participants Philip Shen - ROTH Capital Partners, LLC, Research Division Alan Lau - Jefferies LLC, Research Division Rajiv Chaudhri Tyler Bisset - Goldman Sachs Group, Inc., Research Division Presentation Operator Hello, ladies and gentlemen, and thank you for standing by for JinkoSolar Holding Co., Ltd.

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Freeport-McMoran Inc. (NYSE: FCX) securities between February 15, 2022 and September 24, 2025. Freeport is a mining company.